Hot Life Science Investor Mandate 1: Northeast-Based Family Office Seeking Biotech R&D and Healthcare IT

29 Oct

An investment group is based in Northeastern United States and invests on behalf of family offices and institutions, and makes direct investments in a variety of sectors including healthcare & life science. Investments in early-stage companies are typically in the form of equity, whereas debt investments in later-stage companies may be considered. The firm’s allocations are highly variable but are generally over $1m, and are typically at least $3m. The firm primarily invests in US-based companies but Canada-based and other international companies may also be considered.

Within the life science sector the firm has diverse interests, with a primary focus on healthcare services companies, including biotech R&D services and healthcare IT services. The firm is also interested in medical devices in late-stage clinical trials, or which are already approved. Investments in therapeutic drug development may be considered but only at later stages (Phase II or later).

The firm seeks to invest in solid management teams who are developing a product based on proprietary, patented technology which addresses a large market need. While the firm may consider investments in pre-revenue companies, they require that a company have a defined path to revenues and will be profitable within three years.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: